Evaluation of an Alternative Intravenous N-Acetylcysteine Regimen in Pediatric Patients

Abstract

This alternative IV-NAC regimen appears to be effective and well tolerated among pediatric patients when compared to the FDA-approved regimen. It may also result in fewer reconstitution and administration errors, leading to improved patient safety.